Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gemini Therapeutics Inc (NQ: GMTX )

N/A UNCHANGED
Last Price Updated: 3:59 PM EST, Dec 29, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Gemini Therapeutics Inc

< Previous 1 2 3 Next >
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Gemini Therapeutics, Inc. (GMTX) Investigation
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Why Minerva Surgical Shares Are Trading Higher By 166%; Here Are 26 Stocks Moving Premarket
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 166% to $0.4327 in pre-market trading after the company reported a $30 million private placement of common stock led by Accelmed Partners. 
Via Benzinga
7 Short-Squeeze Stocks for Bold Contrarians to Consider
While market volatility has brough the bears out of hibernation, certain short-squeeze stocks could be a trap for the pessimists. 
Via InvestorPlace
Gemini Therapeutics Announces Reverse Merger Pact With Hematology-Focused Company
Via Benzinga
GEMINI THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Gemini Therapeutics, Inc. - GMTX
From Kahn Swick & Foti, LLC
Via Business Wire
GMTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Merger of Gemini Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
  
Via Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS. 
Via Benzinga
Gemini Therapeutics and Disc Medicine Announce Merger Agreement
From Gemini Therapeutics, Inc.
Via Business Wire
The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
10 Biggest Price Target Changes For Friday
Needham cut the price target on OppFi Inc. (NYSE: OPFI) from $10 to $4.5. OppFi shares rose 5.3% to $3.20 in pre-market trading. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 11, 2022
Upgrades According to B of A Securities, the prior rating for Sabra Health Care REIT Inc (NASDAQ:SBRA) was changed from Underperform to Neutral. In the fourth quarter, Sabra... 
Via Benzinga
What 5 Analyst Ratings Have To Say About Gemini Therapeutics
Within the last quarter, Gemini Therapeutics (NASDAQ:GMTX) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022
Upgrades For Douglas Emmett Inc (NYSE:DEI), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the fourth quarter, Douglas Emmett had an EPS of $0.48,... 
Via Benzinga
10 Biggest Price Target Changes For Thursday
Piper Sandler cut the price target on Bright Health Group, Inc. (NYSE: BHG) from $10 to $5. Bright Health shares rose 3.2% to $2.59 in pre-market trading. 
Via Benzinga
Read Why Did Jefferies Downgrade Gemini Therapeutics To Hold
Jefferies has cut Gemini Therapeutics Inc (NASDAQ: GMTX) to Hold as the Company explores alternatives. The analyst Chris Howerton has also reduced the price target... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 98 companies set new 52-week lows. Intriguing Points From Today's 52-Week Lows And Highs: JPMorgan Chase (NYSE:JPM) was the... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022
Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ:RVMD) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71,... 
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Keybanc cut the price target on Workday, Inc. (NASDAQ: WDAY) from $345 to $312. Workday shares rose 5.7% to $242.00 in pre-market trading. 
Via Benzinga
Gemini Therapeutics Provides Corporate Update
From Gemini Therapeutics, Inc.
Via Business Wire
Gemini Therapeutics Provides GEM103 Program Update
From Gemini Therapeutics, Inc.
Via Business Wire
46 Biggest Movers From Yesterday
Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday. CMC Materials, Inc. (NASDAQ: CCMP) climbed 33.9% to close at $195.50 on... 
Via Benzinga
Mid-Afternoon Market Update: Dow Surges Over 100 Points After Federal Reserve's Policy Update
Toward the end of trading Wednesday, the Dow traded up 0.35% to 35,669.27 while the NASDAQ rose 0.44% to 15,304.76. The S&P also rose, gaining 0.51% to 4,657.83. The U.S. has... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Biofrontera (NASDAQ: 
Via Benzinga
Gemini Therapeutics Shares Jump As HC Wainwright Sees Over 500% Upside
H.C. Wainwright initiated coverage of Gemini Therapeutics Inc (NASDAQ: GMTX) with a Buy rating and $20 price target. In the near term, the expected... 
Via Benzinga
Mid-Day Market Update: REV Group Drops After Q4 Results; CMC Materials Shares Climb
Midway through trading Wednesday, the Dow traded down 0.30% to 35,436.90 while the NASDAQ fell 0.57% to 15,150.48. The S&P also fell, dropping 0.23% to 4,623.57. The U.S. has... 
Via Benzinga
36 Stocks Moving In Wednesday's Mid-Day Session
Gainers Nxt-ID, Inc. (NASDAQ: NXTD) shares gained 28.9% to $3.21 after the company said it was awarded U.S. General Services Administration contract to distribute personal... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE: 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Gemini Therapeutics (NASDAQ:GMTX) shares moved upwards by 32.92% to $3.23 during Wednesday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.